Wednesday November 21, 2018 21:22

Food and Healthcare Press Releases

Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary Heathcare—21 Nov 18

Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Heathcare—20 Nov 18

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Heathcare—20 Nov 18

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by Heathcare—19 Nov 18

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the Heathcare—14 Nov 18

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Heathcare—14 Nov 18

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories

Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Heathcare—14 Nov 18

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson Johnson Vision Set Heathcare—12 Nov 18

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI) and Johnson & Johnson Vision today announced a

TIENS Group Launches Global Expansion Into New Retail Heathcare—12 Nov 18

Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Experience Store in China. Located in the TIENS International Health Industrial Park, the new store features

Medicines We Can Trust Campaign Rallies Mekong Governments and Leaders to Improve Access to Quality Heathcare—07 Nov 18

Cambodian Prime Minister Hun Sen and other leaders from the Greater Mekong Subregion joined hands as part of a global campaign to improve access to quality medicines. The announcement was made during the Phnom Penh Regional Conference on the fight

SI Group Announces New Executive Leadership Heathcare—06 Nov 18

SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced today the company's new executive leadership team. These changes follow the October 15, 2018

Grunenthal Acquires Global Rights for Qutenza(R) Heathcare—06 Nov 18

Grunenthal, the science-focused pharmaceutical company based in Germany, announced today that it has acquired additional global commercial rights for the dermal pain patch Qutenza(R) (8% capsaicin) from Acorda Therapeutics, Inc (USA). Grunenthal is now

MRT invite to free health check in M Care activity Heathcare—06 Nov 18

Bangkok Expressway and Metro Public Company limited (BEM) invite MRT passengers to free health check in "M Care" activity with famous hospitals at the event such as Traditional Chinese Medicine, Thai Traditional Medicine, Conventional medicine and

Merck Launches BioContinuum(TM) Platform for Next-Generation Process Heathcare—06 Nov 18

- New BioContinuum(TM) Platform provides benefits now, with a mind to continuous process of the future - Expanded Pellicon(R) Single-Pass Tangential Flow Filtration to intensify operations in the purification of therapeutic proteins Merck, the vibrant

Thai Patients to Benefit From 3D Preoperative Planning Heathcare—05 Nov 18

Medical clearance and local partnership enable diagnostic use of Materialise Mimics Innovation Suite in Thailand Materialise NV (NASDAQ: MTLS) has been cleared to bring the Materialise Mimics Innovation Suite software (Mimics Medical, 3-matic Medical)

Doctors Talk: Taking Charge of Yourself to Ensure Healthy Aging Heathcare—02 Nov 18

According to the research completed by Chulalongkorn University, College of Population Studies, by 2021, senior citizens (those over 60) will account for 13.8 million or 20% of Thai population, which categorizes us as an "aged society." The government

Breast Aesthetics Company POLYTECH Reveals New Brand Identity at ISAPS Congress, Focusing on Heathcare—01 Nov 18

POLYTECH Health & Aesthetics GmbH, an international leader in Breast Aesthetics, announced today the launch of the new POLYTECH company branding and a new company website. POLYTECH Health & Aesthetics GmbH launches its new brand image at the

Grunenthal Agrees US$ 922 m Deal With AstraZeneca for Nexium and Vimovo Heathcare—30 Oct 18

- Biggest single investment in Gruenenthal's history that will significantly strengthen the company's leading position in pain management - Gastroprotective therapies to address a high unmet medical need[1] in pain patients on non-steroidal

Bumrungrad International Hospital Implements InterSystems TrakCare with Early Benefits to Patient Heathcare—30 Oct 18

Eighteen-Month Digital Transformation Leads to Record High Patient Satisfaction Ratings in Several Departments at World Class, Multi-Specialty Private Hospital InterSystems, a global leader in health information technology, and Bumrungrad International

ผลการศึกษาทางคลินิกระยะที่ 3 เผย ผู้ป่วยโรคอัลไซเมอร์เล็กน้อยถึงปานกลางในจีนมีความจำดีขึ้นเมื่อรักษา Heathcare—26 Oct 18

- Green Valley Pharmaceutical Company ได้ยื่นคำขอขึ้นทะเบียนตำรับยาใหม่ (New Drug Application) และการอนุญาตจำหน่าย (Market Authorization) ผลิตภัณฑ์ยา Sodium Oligomannurarate (GV-971) ต่อสำนักงานอาหารและยาของจีน (CFDA) ในการประชุม Clinical Trials on

Novel Drug Treatment Shows Improved Cognition in a Phase 3 Clinical Trial in Persons with Heathcare—26 Oct 18

- Green Valley Pharmaceutical Company has submitted New Drug Applications and Market Authorization to China Food and Drug Administration (CFDA) for Sodium Oligomannurarate (GV-971) Green Valley Pharmaceutical Co., Ltd. (Headquarter: Shanghai) announced

Improving the Quality of Patient Care: Finalists revealed for the Asia Pacific HIMSS-Elsevier Heathcare—24 Oct 18

- North Asia and the Pacific Regions lead in Outstanding ICT Achievement and Outstanding ICT Innovation Categories Elsevier, the information analytics business specializing in science and health, and HIMSS Asia Pacific have announced the finalists of

Merck Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Heathcare—24 Oct 18

- New data presented at the ESMO 2018 Congress include first disclosure of results for M7824 in advanced squamous cell carcinoma of the head and neck, biliary tract cancer and esophageal cancers - Updated data also being presented include non-small cell

Menarini Progresses Into the Clinic With MEN1611, a PI3K Inhibitor for the Treatment of HER2 Heathcare—19 Oct 18

Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety and efficacy of MEN1611 plus trastuzumab with or without fulvestrant. The study will enroll patients with